Sponsor pipeline

Disc Medicine, Inc clinical trial pipeline

Get alerts when Disc Medicine, Inc's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
1
Phase 2
2
Phase 2/3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT05883748 HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability… Erythropoietic Protoporphyria Enrolling by Invitation 2026-10-09
Phase 2
NCT07368972 Study of DISC-0974-201 in Participants With IBD and Anemia Inflammatory Bowel Disease (IBD) Recruiting 2026-09-23
NCT06985147 A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV) Polycythemia Vera (PV) Active, Not Recruiting 2026-07-31
Phase 1/2
NCT05320198 Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic… Myelofibrosis; Anemia Recruiting 2026-09-23
Phase 1
NCT07187973 A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) Sickle Cell Disease Recruiting 2026-10-05

Disease areas by active trials

Myelodysplastic Syndromes (MDS) (1) · Myelofibrosis (1) · Sickle Cell Disease (1)

Get alerts when Disc Medicine, Inc's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free